Results 31 to 40 of about 305,984 (384)

Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench

open access: yesBiomolecules, 2023
Over recent years, preclinical and clinical evidence has implicated myocardial inflammation (M-Infl) in the pathophysiology and phenotypes of traditionally genetic cardiomyopathies. M-Infl resembling myocarditis on imaging and histology occurs frequently
G. Peretto   +8 more
semanticscholar   +1 more source

Sudden cardiac death in young athletes: Literature review of molecular basis [PDF]

open access: yes, 2020
Intense athletic training and competition can rarely result in sudden cardiac death (SCD). Despite the introduction of pre-participation cardiovascular screening, especially among young competitive athletes, sport-related SCD remains a debated issue ...
Barbara Lombardo   +5 more
core   +1 more source

Lyme Carditis: From Pathophysiology to Clinical Management

open access: yesPathogens, 2022
Cardiac involvement is a rare but relevant manifestation of Lyme disease that frequently presents as atrioventricular block (AVB). Immune-mediated injury has been implicated in the pathogenesis of Lyme carditis due to possible cross-reaction between ...
Cinzia Radesich   +7 more
doaj   +1 more source

Stress Cardiomyopathy (Takotsubo Cardiomyopathy) [PDF]

open access: yesClinical medicine. Cardiology, 2009
Background Due to the rise in the number of reports of stress cardiomyopathy in the literature, awareness of this condition is increasing. Although different names have been used to describe this condition, the similarities in clinical, electrocardiographic, echocardiographic and angiographic features suggest that they represent the same spectrum of ...
Samer Khouri, Naser Imran
openaire   +3 more sources

Electrocardiographic abnormalities in patients with cardiomyopathies

open access: yesHeart Failure Reviews, 2023
Abnormalities in impulse generation and transmission are among the first signs of cardiac remodeling in cardiomyopathies. Accordingly, 12-lead electrocardiogram (ECG) of patients with cardiomyopathies may show multiple abnormalities.
Alberto Aimo   +13 more
semanticscholar   +1 more source

Arrhythmogenic Cardiomyopathy [PDF]

open access: yesCirculation Research, 2017
Arrhythmogenic cardiomyopathy is an inherited heart muscle disorder, predisposing to sudden cardiac death, particularly in young patients and athletes. Pathological features include loss of myocytes and fibrofatty replacement of right ventricular myocardium; biventricular involvement is often observed.
Corrado, Domenico   +2 more
openaire   +3 more sources

Heart Failure Subtypes and Cardiomyopathies in Women

open access: yesCirculation Research, 2022
Heart failure affects over 2.6 million women and 3.4 million men in the United States with known sex differences in epidemiology, management, response to treatment, and outcomes across a wide spectrum of cardiomyopathies that include peripartum ...
E. DeFilippis   +6 more
semanticscholar   +1 more source

Clinical application of CMR in cardiomyopathies: evolving concepts and techniques

open access: yesHeart Failure Reviews, 2022
Cardiac magnetic resonance (CMR) has become an essential tool for the evaluation of patients affected or at risk of developing cardiomyopathies (CMPs).
M. Merlo   +23 more
semanticscholar   +1 more source

Myosin modulators: emerging approaches for the treatment of cardiomyopathies and heart failure

open access: yesJournal of Clinical Investigation, 2022
Myosin modulators are a novel class of pharmaceutical agents that are being developed to treat patients with a range of cardiomyopathies. The therapeutic goal of these drugs is to target cardiac myosins directly to modulate contractility and cardiac ...
S. Day, J. Tardiff, E. Ostap
semanticscholar   +1 more source

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms [PDF]

open access: yes, 2014
Aim In the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF), aldosterone blockade with eplerenone decreased mortality and hospitalisation in patients with mild symptoms (New York Heart Association class II ...
Akehurst, R.   +9 more
core   +3 more sources

Home - About - Disclaimer - Privacy